Last updated: April 24, 2026
What does the Austria patent “ATE451914” cover, and how does it sit in the drug patent landscape?
What is “ATE451914” in the Austrian patent system?
No complete and verifiable patent record can be produced from the provided identifier alone. A valid Austria patent analysis requires a uniquely searchable patent bibliographic record (at minimum: publication number, applicant, title, filing/priority dates, and the exact claim set). Without that, the scope and claims cannot be mapped to a defensible “AT/EP/WO” family, claim-by-claim coverage, or freedom-to-operate style landscape.
What claims are in scope for ATE451914?
No claim set can be extracted or reproduced because the underlying patent document is not identifiable from “ATE451914” in a way that supports a complete and accurate analysis.
How does ATE451914 map to a patent family and claim strategy?
A family-level mapping cannot be performed because the record for ATE451914 cannot be reliably linked to:
- a WO publication or EP publication,
- a priority filing,
- INPADOC legal status events,
- or the claim language used across jurisdictions.
What does the competitive landscape look like around this compound/class?
A landscape assessment cannot be produced because the drug identity (molecule, salt, polymorph, formulation, target, indication) tied to ATE451914 is not verifiable from the identifier alone. Landscape work needs the compound name and/or publication numbers to test for:
- overlapping composition-of-matter claims,
- method-of-treatment or use claims,
- device/combination claims,
- second-medical-use coverage,
- polymorph/formulation coverage,
- and patent family breadth by jurisdiction.
Which infringement-risk claim buckets would be relevant if the record were identified?
Without the claim text and the drug identity, any bucket allocation would be speculative. A defensible analysis would break down the claims into buckets such as:
- compound (Markush) claims for the active,
- salt/polymorph claims,
- formulation claims (controlled release, excipients),
- method-of-treatment claims (specific indications, dosing regimens),
- combination claims with co-actives,
- manufacturing/process claims,
- and use claims tied to biomarkers or patient subsets.
How would you score scope strength and enforceability for an Austrian drug patent?
A score would require the actual claim scope, priority chain, term basis, and status (granted, pending, lapsed, opposed, limited). Without the document, an enforceability and scope-strength assessment cannot be delivered.
Key Takeaways
- A complete scope-and-claims analysis cannot be produced for Austria “ATE451914” because the patent document is not uniquely identifiable from the provided identifier in a way that supports extraction of claim language and family mapping.
- A patent landscape cannot be built without the verifiable publication identifiers and the linked drug identity.
- Any attempt to state coverage, claim limitations, or competitive overlaps would not meet the requirements for a high-stakes patent analysis.
FAQs
-
What identifiers are needed to analyze an Austrian drug patent properly?
A verifiable publication number (e.g., AT publication), plus enough bibliographic data to locate the WO/EP family and retrieve the full claim set.
-
Can “ATE451914” alone be used to map claims and family members?
Not reliably; a unique bibliographic match is required to extract claims and legal status.
-
What are the main claim types that drive drug patent scope in Austria?
Composition-of-matter (including salts/polymorphs), formulation, and method-of-treatment/use claims.
-
How is an infringement risk assessed from a patent landscape?
By aligning the product’s molecule/formulation/regimen/indication to the closest independent claims and checking for overlapping claim sets in competing families.
-
How do legal status and term affect Austrian drug patent enforceability?
They determine whether claims are in force, limited, lapsed, or still pending, and they affect the practical window for enforcement and risk.
References
No sources are cited because no verifiable patent record for “ATE451914” was identifiable from the provided identifier.
